SCHEMBL20547503

SCHEMBL20547503

COc1cccc2ncc([N+](=O)[O-])c(O)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
PIN1 Q13526 2/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 3/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.43
MAPK1 P28482 1/20 0.42
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
GPR35 Q9HC97 1/20 0.41
HSP90AA1 P07900 1/20 0.41
PAX8 Q06710 1/20 0.41
KLF5 Q13887 1/20 0.41
GAA P10253 2/20 0.40
PKM P14618 1/20 0.40
DCPS Q96C86 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25959031 0.86 LMNA (0.45) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL20547453 0.84 ALDH1A1 (0.49) ALDH1A1TDP1PIN1KMT2AMEN1
SCHEMBL20547229 0.83 PIN1 (0.52) ALDH1A1TDP1PIN1KMT2AMEN1
SCHEMBL20547230 0.82 ALDH1A1 (0.50) ALDH1A1TDP1PIN1KMT2AMEN1
SCHEMBL10147928 0.81 TSHR (0.45) ALDH1A1TDP1MAPTSMN1; SMN2L3MBTL1
SCHEMBL29206007 0.79 ALDH1A1 (0.49) ALDH1A1TDP1PIN1KMT2AMEN1
SCHEMBL3862305 0.78 GPR35 (0.44) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL31050886 0.76 ALDH1A1 (0.42) ALDH1A1TDP1PIN1KMT2AMEN1
SCHEMBL21712376 0.76 ALDH1A1 (0.42) ALDH1A1TDP1PIN1KMT2AMEN1
SCHEMBL20547564 0.75 ALDH1A1 (0.44) ALDH1A1TDP1PIN1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118515666-A 2-Amino-quinoline derivatives 博笛生物科技有限公司 2024-08-20 CN disclosed
US-11834448-B2 2-amino-quinoline derivatives BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2023-12-05 US disclosed
US-11834448-B2 2-amino-quinoline derivatives BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2023-12-05 US disclosed
EP-3615539-B1 2-AMINO-QUINOLINE DERIVATIVES BIRDIE BIOPHARMACEUTICALS INC (KY) 2023-08-09 EP disclosed
US-11053240-B2 2-amino-quinoline derivatives BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2021-07-06 US disclosed
EP-3615539-A1 2-AMINO-QUINOLINE DERIVATIVES Birdie Biopharmaceuticals, Inc. (KY) 2020-03-04 EP disclosed
US-20200055851-A1 2-AMINO-QUINOLINE DERIVATIVES BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2020-02-20 US disclosed
CN-110637018-A 2-amino-quinoline derivatives 博笛生物科技有限公司 2019-12-31 CN disclosed
WO-2018196823-A1 2-AMINO-QUINOLINE DERIVATIVES BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2018-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053240-B2 2-amino-quinoline derivatives TLR7, TLR8, TLR1 ALDH1A1 2821/4885TDP1 1505/4885PIN1 4746/4885
US-20200055851-A1 2-AMINO-QUINOLINE DERIVATIVES TLR7, TLR8, TLR1 ALDH1A1 2821/4885TDP1 1505/4885PIN1 4746/4885
US-11834448-B2 2-amino-quinoline derivatives TLR7, TLR8, TLR1 ALDH1A1 2821/4885TDP1 1505/4885PIN1 4746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.